References
- Selvaag E., Roald B. Immunohistochemical findings in granuloma faciale. The role of eosinophilic granulocytes. J Eur Acad Dermatol Venereol 2000; 14: 517–18
- Roussaki‐Schulze A., Klimi E., Zafiriou E., Aroni K., Mpaltopoulos A., Aravantinos E., et al. Granuloma faciale associated with adenocarcinoma of prostate. Int J Dermatol 2002; 41: 901–3
- Ludwig E., Allam J. P., Bieber T., Novak N. New treatment modalities for granuloma faciale. Br J Dermatol 2003; 149: 634–7
- Chatrath V., Rohrer T. E. Granuloma faciale successfully treated with long‐pulsed tunable dye laser. Dermatol Surg 2002; 28: 527–9
- Inarır I., Alvur Y. Granuloma faciale with extrafacial lesions. Br J Dermatol 2001; 145: 360–2
- Rousta G., SanchezYus E., Salas C., Simon A. Granuloma faciale with extrafacial lesions. Dermatology 1999; 198: 79–82
- Zargari O. Disseminated granuloma faciale. Int J Dermatol 2004; 43: 210–12
- Yung A., Wachsmuth R., Ramnath R., Merchant W., Myatt A. E., Sheehan‐Dare R., et al. Eosinophilic angiocentric fibrosis – a rare mucosal variant of granuloma faciale which may present to the dermatologist. Br J Dermatol 2005; 152: 565–95
- Ortonne N., Eschler J., Bagot M., Groushans E., Cribier B. Granuloma faciale: A clinicopathologic study of 66 patients. J Am Acad Dermatol 2005; 53: 1002–9
- Ammirati C. T., Hruza G. J. Treatment of granuloma faciale with 585‐nm pulsed dye laser. Arch Dermatol 1999; 135: 903–5
- Welsh J. H., Schroeder T. L., Levy M. L. Granuloma faciale in a child successfully treated with the pulsed dye laser. J Am Acad Dermatol 1999; 41: 351–3
- Lipozencic J. Pimecrolimus – a safe and effective local immunomodulator in the treatment of inflammatory skin diseases. Acta Dermatovenerol Croat 2005; 13: 63–9
- Grassberger M., Steinhoff M., Schneider N., Luger T. A. Pimecrolimus – an anti‐inflammatory drug targeting the skin. Exp Dermatol 2004; 13: 721–30
- Mitchell D. Successful treatment of granuloma faciale with tacrolimus. Dermatol Online J 2004; 10((2))23